In the injured adult mammalian CNS, products are generated that inhibit neuronal sprouting and 21 regeneration. In recent years, most attention has focused on the myelin-associated inhibitory 22 proteins (MAIs), Nogo-A, OMgp, and myelin-associated glycoprotein (MAG). Binding of MAIs 23 to neuronal cell-surface receptors leads to activation of RhoA, growth cone collapse, and neurite 24 outgrowth inhibition. Herein, we identify LDL receptor-related protein-1 (LRP1) as a high-af- clusters, CII and CIV, bind MAG and other MAIs. When CII and CIV were expressed as Fc-35 fusion proteins, these proteins, purified full-length LRP1, and shed LRP1 all attenuated the in-36 hibition of neurite outgrowth caused by MAG and CNS myelin in primary neurons. Collectively, 37 our studies identify LRP1 as a novel MAG receptor that functions in neurite outgrowth inhibition. 38
Summary 20
In the injured adult mammalian CNS, products are generated that inhibit neuronal sprouting and 21 regeneration. In recent years, most attention has focused on the myelin-associated inhibitory 22 proteins (MAIs), Nogo-A, OMgp, and myelin-associated glycoprotein (MAG). Binding of MAIs 23 to neuronal cell-surface receptors leads to activation of RhoA, growth cone collapse, and neurite 24 outgrowth inhibition. Herein, we identify LDL receptor-related protein-1 (LRP1) as a high-af- is comprised of at least two distinct growth inhibitory regions: amino-Nogo and Nogo66 46 (Schwab, 2010) . MAG is a sialic acid-recognizing Ig-family lectin (Tang et Our previous work demonstrating myelin phagocytosis by LRP1 (Gaultier et al., 2009 ) 80 prompted us to examine the role of LRP1 in the mechanism by which myelin inhibits axonal re-81 generation. In this study, we demonstrate that LRP1 is a high-affinity, endocytic MAG receptor, 82 which may be essential for inhibition of neurite outgrowth by MAG and CNS myelin. 83
Results

84
MAG binds to LRP1 85
Full-length LRP1 is a 600-kDa, two-chain transmembrane receptor (Herz et al., 1988) . Two of 86 the four clusters of complement-like repeats (CII and CIV) in the extracellular α -chain of LRP1 87 are responsible for most of the ligand-binding activity of this receptor (Willnow et al., 1994 ). To 88 screen for proteins in CNS myelin that bind to LRP1, we expressed CII and CIV as Fc-fusion 89 proteins (Fig. 1A) . CNS myelin vesicles were purified from rat brain as previously described 90 As a first approach to test whether MAG binds to full-length LRP1, the ectodomain of 97 MAG was expressed as an Fc-fusion protein (MAG-Fc) and incubated with extracts of mouse 98 N2a neuroblastoma cells (Fig. 1B) . MAG-Fc and associated proteins were precipitated with Pro-99 tein A-Sepharose. LRP1 was readily detected in MAG-Fc affinity-precipitates by immunoblot 100 analysis using an antibody that detects the 85-kDa β -chain. LRP1 did not co-precipitate with 101 purified Fc, demonstrating specificity in the MAG-LRP1 interaction. 102
Next, we prepared membrane extracts from rat brain and tested whether endogenous 103 MAG associates with LRP1 in these extracts. Polyclonal rabbit antibodies that are specific for 104 MAG or the LRP1 β -chain were incubated with the brain extracts for 4 h at 4 o C and then preci-105 pitated with Protein A/G-Argarose. Non-specific rabbit IgG was added to the brain extracts and 106 precipitated similarly, as a control. Fig. 1C shows that LRP1 co-immunoprecipitated (co-IPed) 107 with MAG from brain extracts and that MAG co-IPed with LRP1. Neither MAG nor LRP1 co-108
IPed with non-specific IgG. 109
To test whether MAG binds to LRP1 in a purified system, full-length LRP1 was purified 110 from rat liver (Gorovoy et al., 2010) N2a cells were treated with purified Fc or with vehicle, p75NTR did not co-IP with LRP1 at 270 detectable levels (Fig. 6C) . By contrast, when N2a cells were treated with MAG-Fc, p75NTR 271 was found to co-IP with LRP1. Densitometry analysis of p75NTR in cell extracts that were 272 subjected to co-IP suggested that approximately 2-5% of the total cellular p75NTR associated 273 with LRP1 in the presence of MAG-Fc (n=3). Nevertheless, complex formation between 274 p75NTR and LRP1 was induced specifically by MAG, reminiscent of the ability of MAG to 275 induce association of p75NTR with NgR1 and PirB. 276
To test whether p75NTR regulates MAG-binding to LRP1, we achieved partial p75NTR 277 gene-silencing in N20.1 cells (Fig. 6D) . Total cellular LRP1 was not affected by p75NTR gene-278 silencing. MAG-Fc binding to LRP1 was examined by co-IP, 72 h after introducing siRNA. 279
Association of MAG-Fc with LRP1 was not significantly affected by p75NTR gene-silencing. 280
These results suggest that the binding of MAG to LRP1 does not require p75NTR, consistent 281 with the results presented in Fig. 1 . 282
283
LRP1 inhibits neurite outgrowth in cells plated on purified CNS myelin 284
Next, we examined neurite outgrowth inhibition in cells plated on purified rat CNS myelin. 285
Neurite outgrowth in CGNs was inhibited by myelin, as anticipated, and RAP significantly re-286 versed the extent of inhibition (Fig. 7A) . LRP1 gene-silencing also significantly reversed the 287 effects of myelin on neurite outgrowth in CGNs (Fig. 7B) . When PC12 cells were plated on 288 myelin, inhibition of neurite outgrowth inhibition was observed. Adding RAP or silencing LRP1 289 significantly reversed the inhibition of neurite outgrowth (supplementary material Fig. S6 ). 290
As a specificity control, we examined the effects of LRP1 antagonism on neurite out-291 growth in CGNs plated on substrate-bound chondroitin sulfate proteoglycan (CSPGs). The 292
CSPGs strongly inhibited neurite outgrowth; however, RAP failed to reverse the inhibition 293 caused by CSPGs (supplementary material Fig. S7) . 294
295
LRP1 supports binding of Nogo66 and OMgp 296
Purified CNS myelin contains MAIs in addition to MAG. Initially, we tested whether Nogo-A 297 co-IPs with LRP1 from rat brain extracts. Reproducing the protocol utilized in Fig. 1 , we show-298 ed that Nogo-A co-IPs with LRP1 and vice versa (Fig. 7C) . Furthermore, Nogo-A and OMgp in 299 purified rat CNS myelin co-IPed with CII-Fc and CIV-Fc, but not Fc (Fig. 7D, E) . 300
As an additional confirmation, OMgp and Nogo66 were expressed as fusion proteins with 301 alkaline phosphatase (OMgp-AP and AP-Nogo66). These fusion proteins were incubated with 302 CII-Fc, CIV-Fc, and Fc, which were pre-immobilized on nitrocellulose. Fig. 7F shows that 303
OMgp-AP and AP-Nogo66 bound to CII-Fc and CIV-Fc but not to Fc, suggesting that these 304 interactions occur in purified systems. Overall, these qualitative binding studies demonstrate that 305 LRP1 may interact with MAIs other than MAG. Additional studies will be needed to understand 306 the significance of these interactions. 307 308
Soluble forms of LRP1 reverse the effects of MAIs on neurite outgrowth on primary 309 neurons 310
We hypothesized that purified LRP1 and LRP1 derivatives that retain ligand-binding activity 311 may compete for MAI-binding with membrane-anchored LRP1 and other MAI receptors and 312 thereby reverse the activity of MAIs. To test this hypothesis, first we examined the effects of 313 purified full-length LRP1 on neurite outgrowth in CGNs. Purified LRP1 did not affect neurite 314 outgrowth when it was added to CGNs that were cultured on control R2-CHO cells (Fig. 8A) . 315
When CGNs were cultured on MAG-CHO cells, purified LRP1 significantly reversed the inhi-316 bition of neurite outgrowth observed. Purified LRP1 also significantly reversed the inhibition of 317 neurite outgrowth observed when CGNs were plated on purified rat CNS myelin (Fig. 8B) . 318 LRP1 is released from cells as a of rat CGNs were isolated as previously described (Oberdoerster, 2001 ) and cultured in DMEM 443 with 50 mM glucose, 10% FBS, 25 mM KCl, and P/S. Mouse CGNs were isolated, purified in a 444 discontinuous Percoll gradient, and cultured as previously described (Dickendesher et al., 2012) . 445 N20.1 cells were a gift from Dr. Anthony Campagnoni (University of California Los Angeles) 446
and were cultured as previously described (Wight and Dobretsova, 1997) . 447
448
CNS myelin purification 449
Myelin vesicles were purified from rat brain, as described by Norton and Poduslo (Norton and 450 Poduslo, 1973) . The purity of the preparation was determined by Coomassie Blue staining and 451 by immunoblot analysis for myelin basic protein, as previously described (Gaultier et al., 2009) . 452
453
Mass spectrometry 454
Purified rat CNS myelin was solubilized in RIPA buffer (100 mM Tris-HCl, 150 mM NaCl, 1% 455
Triton X-100, 0.5% deoxycholate, 0.1% SDS, 1 mM CaCl2, and protease inhibitor cocktail). but not Fc, were identified by LC-MS/MS as previously described . 461
Solution-phase protein-binding experiments 463
Protein extracts from cells were prepared in 50 mM HEPES pH 7.4, 1% Triton X-100, 150 mM 464 NaCl, 10% glycerol, 2 mM EDTA, 1 mM sodium orthovanadate, and protease inhibitor cocktail. Cambridge, MA). 72 h later, the transduced CGNs were extracted for immunoblot analysis or 511 gently dislodged using Cellstripper™ non-enzymatic cell dissociation solution (Corning, Corn-512 ing, NY) and re-plated on CHO cells or purified myelin to assess neurite outgrowth. Control 513 substrate included CSPGs (10 μ g/ml) (Millipore, Temecula, CA) and laminin (2 μ g/ml) which 514 were adsorbed to culture wells for 2 h at 22 o C. When RAP or GST was added, these proteins 515
were pre-incubated with CGNs or neurite-generating cell lines in suspension for 15 min. Shed 516 LRP1, purified LRP1, CII-Fc, or CIV-Fc also were pre-incubated with cells. Neurite outgrowth 517
was assessed by immunofluorescence microscopy, after immunostaining to detect β III-tubulin 518 (Promega, Madison, WI) and quantified using ImageJ or Metamorph software. 519
520
Gene silencing 521 PC12 cells were transfected with the previously described rat LRP1-specific siRNA 522 (CGAGCGACCUCCUAUCUUUUU) or with NTC siRNA using the Amaxa rat neuron 523 nucleofector kit. LRP1 was silenced in rat CGNs and mouse N2a cells using ON-TARGET plus, 524 smart-pool LRP1-specific siRNA (Thermo Scientific, Lafayette, CO) and Lipofectamine 2000 525 (Invitrogen, Carlsbad, CA, USA). Stable LRP1 gene silencing was achieved in N2a cells using 526 our previously described LRP1-specific shRNA, cloned into pSUPER (Gaultier et al., 2008) . 527 
